Kriya Therapeutics
Morrisville, North Carolina, United States · Biotechnology, research · 199 employees
Kriya is a biopharmaceutical company on a mission to revolutionize medicine by developing gene therapies that aim to eliminate human suffering and free people from the burden of chronic disease. With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $600 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease, a
Funding history
- Venture - Series Unknown — $320.8M — Sep 2025
- Venture - Series Unknown — $313.3M — Aug 2025
- Venture - Series Unknown — $361.8M — Jul 2023
- Series C — Undisclosed — Jul 2023
- Venture - Series Unknown — $270.5M — May 2022
Recent signals
- Sep 10, 2025: Raised $320.8M in Venture - Series Unknown
- Aug 15, 2025: Raised $313.3M in Venture - Series Unknown
- Jul 27, 2023: Raised $361.8M in Venture - Series Unknown
- Jul 26, 2023: Raised funding in Series C
- May 24, 2022: Raised $270.5M in Venture - Series Unknown
- Jul 14, 2021: Raised $320.8M in Venture - Series Unknown
- Aug 18, 2020: Raised $87.6M in Venture - Series Unknown
See plans & pricing → Track Kriya Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.